期刊
CHEMISTRY & BIOLOGY
卷 12, 期 1, 页码 99-107出版社
CELL PRESS
DOI: 10.1016/j.chembiol.2004.11.009
关键词
-
资金
- NCI NIH HHS [2R44 CA 097462-02] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [R44CA097462] Funding Source: NIH RePORTER
Polo-like kinases (PLKs) play critical roles throughout mitosis. Here, we report that wortmannin, which was previously thought to be a highly selective inhibitor of phosphoinositide (PI) 3-kinases, is a potent inhibitor of mammalian PLK1. Observation of the wortmannin-PLK1 interaction was enabled by a tetra-methylrhodamine-wortmannin conjugate (AX7503) that permits rapid detection of PLK1 activity and expression in complex proteomes. Importantly, we show that wortmannin inhibits PLK1 activity in an in vitro kinase assay with an IC50 of 24 nM and when incubated with intact cells. Taken together, our results indicate that, at the concentrations of wortmannin commonly used to inhibit PI 3-kinases, PLK1 is also significantly inhibited.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据